Manta
Payments companies reported to CMS as associated with Manta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Manta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Manta
These are the largest totals companies reported as associated with Manta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Siddharth Wayangankar | Jacksonville, FL | Interventional Cardiology | $72,861.10 |
| Pedro Villablanca Spinetto | Detroit, MI | Cardiovascular Disease | $14,328.88 |
| Dennis Gable | Dallas, TX | Vascular Surgery | $13,506.11 |
| Salman Arain | Houston, TX | Interventional Cardiology | $8,188.19 |
| William Nicholson | Atlanta, GA | Interventional Cardiology | $7,427.06 |
| Jimmy Kerrigan | Nashville, TN | Interventional Cardiology | $6,497.23 |
| Ankur Garg | Chicago, IL | Diagnostic Radiology | $6,391.34 |
| Halim Yammine | Tampa, FL | Vascular Surgery | $6,370.32 |
| David Baran | Weston, FL | Advanced Heart Failure and Transplant Cardiology | $6,289.08 |
| Robert Meisner | Lebanon, PA | Vascular Surgery | $4,800.00 |
Prescribed Manta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.